Focus Financial Network’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.07M | Buy |
44,319
+1,662
| +4% | +$43.5K | 0.03% | 331 |
|
|
2026
Q1 | $1.2M | Sell |
42,657
-13,821
| -24% | -$368K | 0.04% | 290 |
|
|
2025
Q4 | $1.41M | Buy |
56,478
+9,294
| +20% | +$234K | 0.05% | 258 |
|
|
2025
Q3 | $1.2M | Sell |
47,184
-3,885
| -8% | -$95.9K | 0.04% | 274 |
|
|
2025
Q2 | $1.24M | Buy |
51,069
+3,547
| +7% | +$82.7K | 0.05% | 261 |
|
|
2025
Q1 | $1.2M | Buy |
47,522
+607
| +1% | +$15.9K | 0.05% | 259 |
|
|
2024
Q4 | $1.24M | Sell |
46,915
-5,068
| -10% | -$137K | 0.05% | 251 |
|
|
2024
Q3 | $1.5M | Sell |
51,983
-5,637
| -10% | -$164K | 0.06% | 216 |
|
|
2024
Q2 | $1.73M | Sell |
57,620
-2,969
| -5% | -$81.7K | 0.07% | 192 |
|
|
2024
Q1 | $1.54M | Sell |
60,589
-49,858
| -45% | -$1.38M | 0.08% | 202 |
|
|
2023
Q4 | $3.18M | Buy |
110,447
+35,193
| +47% | +$1.06M | 0.12% | 153 |
|
|
2023
Q3 | $2.5M | Buy |
75,254
+8,902
| +13% | +$315K | 0.14% | 126 |
|
|
2023
Q2 | $2.43M | Buy |
66,352
+3,176
| +5% | +$124K | 0.14% | 130 |
|
|
2023
Q1 | $2.58M | Buy |
63,176
+776
| +1% | +$33.5K | 0.16% | 122 |
|
|
2022
Q4 | $3.2M | Sell |
62,400
-4,685
| -7% | -$225K | 0.26% | 81 |
|
|
2022
Q3 | $2.94M | Buy |
67,085
+552
| +0.8% | +$26.8K | 0.25% | 82 |
|
|
2022
Q2 | $3.49M | Buy |
66,533
+2,790
| +4% | +$142K | 0.29% | 72 |
|
|
2022
Q1 | $3.3M | Sell |
63,743
-11,951
| -16% | -$620K | 0.23% | 84 |
|
|
2021
Q4 | $4.47M | Buy |
75,694
+18,694
| +33% | +$926K | 0.65% | 35 |
|
|
2021
Q3 | $2.45M | Sell |
57,000
-590
| -1% | -$26.1K | 0.33% | 79 |
|
|
2021
Q2 | $2.26M | Sell |
57,590
-1,724
| -3% | -$67K | 0.3% | 89 |
|
|
2021
Q1 | $2.15M | Buy |
59,314
+6,902
| +13% | +$245K | 0.25% | 95 |
|
|
2020
Q4 | $1.93M | Buy |
52,412
+7,269
| +16% | +$267K | 0.17% | 117 |
|
|
2020
Q3 | $1.57M | Buy |
45,143
+2,928
| +7% | +$103K | 0.15% | 137 |
|
|
2020
Q2 | $1.31M | Buy |
42,215
+731
| +2% | +$24.8K | 0.15% | 134 |
|
|
2020
Q1 | $1.28M | Sell |
41,484
-1,334
| -3% | -$45.5K | 0.17% | 118 |
|
|
2019
Q4 | $1.59M | Buy |
42,818
+3,870
| +10% | +$138K | 0.2% | 109 |
|
|
2019
Q3 | $1.33M | Buy |
38,948
+2,684
| +7% | +$97.6K | 0.18% | 110 |
|
|
2019
Q2 | $1.49M | Sell |
36,264
-834
| -2% | -$33.1K | 0.22% | 95 |
|
|
2019
Q1 | $1.49M | Buy |
+37,098
| New | +$1.49M | 0.24% | 84 |
|
Other funds holding PFE
Focus Financial Network's PFE Position: Q2 2026 in Review
Focus Financial Network increased its Pfizer (PFE) stake by 3.9% in Q2 2026, buying an estimated $43.5K and bringing the position to 44,319 shares worth $1.07M. The position accounts for 0.03% of the portfolio, ranked #331.
Focus Financial Network first reported a position in PFE in Q1 2019 and has held it in 30 quarters since. The position peaked at $4.47M in Q4 2021. 2,824 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Focus Financial Network held 44,319 shares of Pfizer worth $1.07M as of Q2 2026.
- Focus Financial Network bought 1,662 Pfizer shares in Q2 2026, an estimated $43.5K.
- Pfizer made up 0.03% of Focus Financial Network's portfolio in Q2 2026, its #331 holding.
- Focus Financial Network first reported a position in Pfizer in Q1 2019 and has held it in 30 quarters since.
- Focus Financial Network's Pfizer position peaked at $4.47M in Q4 2021.
- 2,824 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Focus Financial Network's 13F filing for Q2 2026, filed 9 Jul 2026.